We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
-0.65%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$16.4B
AUM Growth
-$1.47B
(-8.2%)
Cap. Flow
-$872M
Cap. Flow
% of AUM
-5.32%
Top 10 Holdings %
Top 10 Hldgs %
29.28%
Holding
734
New
154
Increased
144
Reduced
129
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$426M |
| 2 |
Apple
AAPL
|
+$422M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$271M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$102M |
| 5 |
Union Pacific
UNP
|
+$91.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$105M |
| 2 |
Microsoft
MSFT
|
+$76.6M |
| 3 |
Fox Class A
FOXA
|
+$58.2M |
| 4 |
Viatris
VTRS
|
+$53.9M |
| 5 |
Snowflake
SNOW
|
+$53.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.25% |
| 2 | Healthcare | 5.9% |
| 3 | Consumer Staples | 2.48% |
| 4 | Communication Services | 1.8% |
| 5 | Financials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Ardelyx
ARDX
$997M
| $81.4K | ﹤0.01% |
+19,953
| New | +$77.8K |
|
452
Genworth Financial
GNW
$3.7B
| $79.6K | ﹤0.01% |
13,588
-3,104
| -19% | -$17.9K |
|
453
CALL
DexCom
DXCM
$33.1B
| $74.6K | ﹤0.01% |
+800
| New | +$90.2K |
|
454
Fate Therapeutics
FATE
$322M
| $74.6K | ﹤0.01% |
35,173
+19,787
| +129% | +$65.6K |
|
455
Future Fuel
FF
$226M
| $73.6K | ﹤0.01% |
+10,266
| New | +$84.1K |
|
456
PNC Financial Services
PNC
$100B
| $73.4K | ﹤0.01% |
598
-64,106
| -99% | -$8.07M |
|
457
uniQure
QURE
$3.2B
| $72.8K | ﹤0.01% |
+10,844
| New | +$97.6K |
|
458
CALL
Marvell Technology
MRVL
$187B
| $70.4K | ﹤0.01% |
+1,300
| New | +$76.7K |
|
|
DMRA
459
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
| $63.7K | ﹤0.01% |
3,543
-4,083
| -54% | -$160K |
|
|
ETWO
460
DELISTED
E2open Parent Holdings
ETWO
| $58.6K | ﹤0.01% |
+12,912
| New | +$63.9K |
|
461
Stagwell
STGW
$2.22B
| $58.6K | ﹤0.01% |
+12,487
| New | +$73.9K |
|
|
VIGL
462
DELISTED
Vigil Neuroscience
VIGL
| $58.4K | ﹤0.01% |
10,839
-88,850
| -89% | -$614K |
|
463
McDonald's
MCD
$194B
| $54.5K | ﹤0.01% |
+207
| New | +$59K |
|
464
PUT
Micron Technology
MU
$972B
| $54.4K | ﹤0.01% |
+800
| New | +$53.6K |
|
465
PUT
American Express
AXP
$229B
| $44.8K | ﹤0.01% |
300
| – | – |
|
|
OPT
466
DELISTED
Opthea Limited American Depositary Shares
OPT
| $39K | ﹤0.01% |
22,652
| – | – |
|
467
Emergent Biosolutions
EBS
$229M
| $37.4K | ﹤0.01% |
+11,012
| New | +$61K |
|
|
BCEL
468
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $37.3K | ﹤0.01% |
142,824
-286,352
| -67% | -$181K |
|
|
TBLAW
469
DELISTED
Taboola.com Ltd Warrant
TBLAW
| $36.5K | ﹤0.01% |
85,000
| – | – |
|
|
AMTI
470
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $34.2K | ﹤0.01% |
217,828
-169,555
| -44% | -$45.1K |
|
471
PUT
Las Vegas Sands
LVS
$29.4B
| $32.1K | ﹤0.01% |
700
-196,800
| -100% | -$10.6M |
|
472
NewAmsterdam Pharma Warrant
NAMSW
$79.1M
| $31.7K | ﹤0.01% |
16,666
| – | – |
|
473
CALL
Intuitive Surgical
ISRG
$139B
| $29.2K | ﹤0.01% |
100
-32,200
| -100% | -$10.1M |
|
474
PUT
Merck
MRK
$323B
| $10.3K | ﹤0.01% |
100
-199,900
| -100% | -$21.5M |
|
475
CALL
Morgan Stanley
MS
$338B
| $8.17K | ﹤0.01% |
100
-264,600
| -100% | -$23M |
|
Similar funds
AFM
GCP
LCM
MAP
MA
NSAM
ABI
OCM
Laurion Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Laurion Capital Management held 734 positions worth $16.4B, down 8.2% from $17.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Laurion Capital Management withdrew a net $872M in Q3 2023, closing 253 positions and reducing 129 holdings. Its most notable exit was Microsoft, an estimated $76.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.3% of assets, up from 2.5% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Laurion Capital Management opened a new position in Apple worth $394M.
- Laurion Capital Management's largest Q3 2023 buy was Apple: 2,300,879 shares worth $394M.
- Laurion Capital Management added most to Kenvue in Q3 2023, an estimated $426M increase.
- Laurion Capital Management's biggest Q3 2023 reduction was Vistra, cutting an estimated $105M.
- Laurion Capital Management fully exited Microsoft in Q3 2023, selling an estimated $76.6M.
- Laurion Capital Management's ten largest holdings make up 29% of its $16.4B portfolio in Q3 2023.
- Laurion Capital Management opened 154 new positions and closed 253 in Q3 2023.
- Laurion Capital Management's portfolio value fell 8.2% quarter-over-quarter to $16.4B.
Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.